{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:42:19Z","timestamp":1794379339441,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multiple myeloma (MM) is the third most common hematologic malignancy with increasing importance due to improving treatment strategies and long-term outcomes in an aging population. This study aims to analyse influencing factors on health-related quality of life (HRQoL), such as treatment strategies, participation in a clinical trial and patient characteristics like anxiety, depression, gender, and age. A better understanding of the individual factors in context with HRQoL could provide a helpful instrument for clinical decisions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective observational study, the HRQoL of MM patients with different therapies (first-line and relapse) was quantified by standardized questionnaires (EORTC QLQ-C30 and -MY20) in the context of sociodemographic data, individual anxiety and depressiveness (PHQ-4), and a selected number of clinical parameters and symptoms at defined time-points before, during, and after therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 70 patients were included in the study. The median age of the study cohort was 62\u00a0years. 44% were female and 56% were male patients. More than half of the patients were fully active with an ECOG 0. Global health status was significantly higher in patients with first-line treatment and even increased after start of therapy, while the pain level decreased. In contrast, patients with relapsed MM reported a decreasing global health status and increasing pain. Additionally, there was a higher global health status in less anxious\/depressive patients. HRQoL decreased significantly after start of chemotherapy in the parameters body image, side effects of treatment, and cognitive functioning. Tandem stem-cell transplantation was not found to be a risk factor for higher impairment of HRQoL. Participation in a clinical study led to an improvement of most aspects of HRQoL. Among others, increased anxiety and depression, female gender, older age, impaired performance status, and recurrent disease can be early indicators for a reduced HRQoL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study showed the importance of regular longitudinal assessments of patient reported outcomes (PROs) in routine clinical care. For the first time, to our knowledge, we were able to demonstrate a potential impact between participation in clinical trials and HRQoL. However, due to frequently restrictive inclusion criteria for clinical trials, these MM patients might not be directly comparable with patients treated within standard therapy concepts. Further studies are needed to clarify the relevance of this preliminary data in order to develop an individualized, patient-centred, therapy concept.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10101-9","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T10:06:23Z","timestamp":1664791583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study"],"prefix":"10.1186","volume":"22","author":[{"given":"Julia","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Danhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"6","key":"10101_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10101_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbmt.2008.09.023","volume":"15","author":"AC Sherman","year":"2009","unstructured":"Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(1):12\u201320.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10101_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol. 2009;83(2):139\u201348.","journal-title":"Eur J Haematol"},{"issue":"6","key":"10101_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1158\/1078-0432.CCR-10-1925","volume":"17","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Attal M, Roussel M. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival. Clin Cancer Res. 2011;17(6):1253\u201363.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10101_CR5","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516\u201320.","journal-title":"Blood"},{"issue":"11","key":"10101_CR6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1634\/theoncologist.2011-0229","volume":"16","author":"D Pulte","year":"2011","unstructured":"Pulte D, Gondos A, Brenner H. Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data. Oncologist. 2011;16(11):1600\u20133.","journal-title":"Oncologist"},{"issue":"2","key":"10101_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00520-012-1548-y","volume":"21","author":"S Acaster","year":"2013","unstructured":"Acaster S, Gaugris S, Velikova G, Yong K, Lloyd AJ. Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey. Support Care Cancer. 2013;21(2):599\u2013607.","journal-title":"Support Care Cancer"},{"issue":"10","key":"10101_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/leu.2013.185","volume":"27","author":"P Sonneveld","year":"2013","unstructured":"Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia. 2013;27(10):1959\u201369.","journal-title":"Leukemia"},{"issue":"6","key":"10101_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ejh.12012","volume":"89","author":"TR Osborne","year":"2012","unstructured":"Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. What issues matter most to people with multiple myeloma and how well are we measuring them? a systematic review of quality of life tools. Eur J Haematol. 2012;89(6):437\u201357.","journal-title":"Eur J Haematol"},{"issue":"11","key":"10101_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284\u201392.","journal-title":"Med Care"},{"issue":"2","key":"10101_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpsychores.2004.09.006","volume":"58","author":"B L\u00f6we","year":"2005","unstructured":"L\u00f6we B, Kroenke K, Gr\u00e4fe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163\u201371.","journal-title":"J Psychosom Res"},{"issue":"5","key":"10101_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JB, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"1\u20132","key":"10101_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B Lowe","year":"2010","unstructured":"Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1\u20132):86\u201395.","journal-title":"J Affect Disord"},{"issue":"6","key":"10101_CR14","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613\u201321.","journal-title":"Psychosomatics"},{"key":"10101_CR15","doi-asserted-by":"publisher","unstructured":"Alobaidi A, Nabulsi NA, Talon B, Asfaw AA, Zhou J, Sharp LK, et al. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Support Care Cancer. 2020;28(9):4097\u2013106.\u00a0https:\/\/doi.org\/10.1007\/s00520-019-05246-6. Epub 2019 Dec 23.","DOI":"10.1007\/s00520-019-05246-6"},{"key":"10101_CR16","doi-asserted-by":"publisher","unstructured":"Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, et al. Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer.\u00a02014;22(2):417\u201326. https:\/\/doi.org\/10.1007\/s00520-013-1991-4.","DOI":"10.1007\/s00520-013-1991-4"},{"issue":"5","key":"10101_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/ejh.12790","volume":"97","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, et al. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol. 2016;97(5):416\u201329.","journal-title":"Eur J Haematol"},{"issue":"1","key":"10101_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12885-021-08325-2","volume":"21","author":"S Knop","year":"2021","unstructured":"Knop S, Mateos MV, Dimopoulos MA, Suzuki K, Jakubowiak A, Doyen C, et al. Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial. BMC Cancer. 2021;21(1):659.","journal-title":"BMC Cancer"},{"issue":"1","key":"10101_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/blood-2019-131281","volume":"134","author":"V Dhir","year":"2019","unstructured":"Dhir V, Zibdawi L, Paul HK, Espin-Garcia O, Chen CI, Crump M, et al. Quality of life and caregiver burden in patients and their caregivers undergoing outpatient autologous stem cell transplantation compared to inpatient transplantation. Blood. 2019;134(1):62.","journal-title":"Blood."},{"issue":"9","key":"10101_CR20","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1016\/j.clml.2021.05.002","volume":"21","author":"MS Ebraheem","year":"2021","unstructured":"Ebraheem MS, Seow H, Balitsky AK, Pond GR, Wildes TM, Sivapathasundaram B, et al. Trajectory of symptoms in patients undergoing autologous stem cell transplant for multiple myeloma: a population-based cohort study of patient-reported outcomes. Clin Lymphoma Myeloma Leuk. 2021;21(9):e714\u201321.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10101_CR21","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.clml.2018.08.019","volume":"19","author":"N Despiegel","year":"2019","unstructured":"Despiegel N, Touboul C, Flinois A, Saba G, Suzan F, Gonzalez-McQuire S, et al. Health-related quality of life of patients with multiple myeloma treated in routine clinical practice in France. Clin Lymphoma Myeloma Leuk. 2019;19(1):e13\u201328.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10101_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17474086.2019.1634541","volume":"12","author":"M Martino","year":"2019","unstructured":"Martino M, Rossi M, Ferreri A, Loteta B, Morabito A, Moscato T, et al. Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. Expert Rev Hematol. 2019;12(8):665\u201384.","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10101_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-0609.2004.00346.x","volume":"74","author":"CA Uyl-de Groot","year":"2005","unstructured":"Uyl-de Groot CA, Buijt I, Gloudemans IJ, Ossenkoppele GJ, Berg HP, Huijgens PC. Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol. 2005;74(2):136\u201343.","journal-title":"Eur J Haematol"},{"issue":"4","key":"10101_CR24","first-page":"350","volume":"55","author":"L Slovacek","year":"2008","unstructured":"Slovacek L, Slovackova B, Pavlik V, Hrstka Z, Macingova Z, Jebavy L, et al. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. Neoplasma. 2008;55(4):350\u20135.","journal-title":"Neoplasma"},{"issue":"3","key":"10101_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/bjh.14058","volume":"174","author":"D Robinson Jr","year":"2016","unstructured":"Robinson D Jr, Esseltine DL, Regnault A, Meunier J, Liu K, van de Velde H. The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials. Br J Haematol. 2016;174(3):368\u201381.","journal-title":"Br J Haematol"},{"issue":"2","key":"10101_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S1478951513000849","volume":"13","author":"CD Bergerot","year":"2015","unstructured":"Bergerot CD, Clark KL, Nonino A, Waliany S, Buso MM, Loscalzo M. Course of distress, anxiety, and depression in hematological cancer patients: Association between gender and grade of neoplasm. Palliat Support Care. 2015;13(2):115\u201323.","journal-title":"Palliat Support Care"},{"issue":"8","key":"10101_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jgo.2020.05.004","volume":"11","author":"H Mian","year":"2020","unstructured":"Mian H, Pond GR, Tuchman SA, Fiala MA, Wildes TM. Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment. J Geriatr Oncol. 2020;11(8):1279\u201384.","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10101_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557\u201365.","journal-title":"J Clin Oncol"},{"issue":"12","key":"10101_CR29","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1007\/s00520-021-06351-1","volume":"29","author":"N Erickson","year":"2021","unstructured":"Erickson N, Schinkoethe T, Eckhardt C, Storck L, Joos A, Liu L, et al. Patient-reported outcome measures obtained via E-Health tools ease the assessment burden and encourage patient participation in cancer care (PaCC Study). Support Care Cancer. 2021;29(12):7715\u201324.","journal-title":"Support Care Cancer."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10101-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T10:07:22Z","timestamp":1664791642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10101"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10101-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The study protocol, informed consent forms, and other study-related documents were reviewed and approved by the local ethics committee of the Medical Faculty of University of Wuerzburg (votum-no 301\/12). Written informed consent was obtained from all patients. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1032"}}